Organic–inorganic lead halide perovskites have shown photovoltaic performances above 20% in a range of solar cell architectures while offering simple and low-cost processability. Despite the multiple ionic compositions that have been reported so far, the presence of organic constituents is an essential element in all of the high-efficiency formulations, with the methylammonium and formamidinium cations being the sole efficient options available to date. In this study, we demonstrate improved material stability after the incorporation of a large organic cation, guanidinium, into the MAPbI3 crystal structure, which delivers average power conversion efficiencies over 19%, and stabilized performance for 1,000 h under continuous light illumination, a fundamental step within the perovskite field.
Organic-inorganic hybrid perovskites have attracted significant attention owing to their extraordinary optoelectronic properties with applications in the fields of solar energy, lighting, photodetectors, and lasers. The rational design of these hybrid materials is a key factor in the optimization of their performance in perovskite-based devices. Herein, a mechanochemical approach is proposed as a highly efficient, simple, and reproducible method for the preparation of four types of hybrid perovskites, which were obtained in large amounts as polycrystalline powders with high purity and excellent optoelectronics properties. Two archetypal three-dimensional (3D) perovskites (MAPbI and FAPbI ) were synthesized, together with a bidimensional (2D) perovskite (Gua PbI ) and a "double-chain" one-dimensional (1D) perovskite (GuaPbI ), whose structure was elucidated by X-ray diffraction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.